Stockreport

OncoSec launches mid-stage study of TAVO + Keytruda in TNBC [Seeking Alpha]

OncoSec Medical Incorporated  (ONCS) 
Last oncosec medical incorporated earnings: 12/13 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: oncosec.com/tag/investor-relations
PDF OncoSec Medical (NASDAQ: ONCS ) initiates an open-label Phase 2 clinical trial, KEYNOTE-890 , evaluating the combination of TAVO (intratumoral plasma-encoded [Read more]